StreetInsider.com News Articles

AdvisorShares responds to Trump cannabis reclassification order

Thu, 18 Dec 2025 16:41:28 -0500

AdvisorShares issued a statement responding to President Donald J. Trump's executive order directing federal agencies to advance the reclassification of cannabis under the Controlled Substances Act.

Dan Ahrens, Managing Director at AdvisorShares and portfolio manager of the AdvisorShares Pure US Cannabis ETF (MSOS), called the executive action "the clearest and most coordinated federal signal we've ever seen on cannabis policy." Ahrens stated that rescheduling has moved from speculation to sustained engagement at the highest levels of government.

The portfolio manager noted that while the action does not resolve every regulatory hurdle, it represents a step forward for more than 400,000 American cannabis

AdvisorShares responds to Trump cannabis reclassification order

Thu, 18 Dec 2025 16:41:28 -0500

AdvisorShares issued a statement responding to President Donald J. Trump's executive order directing federal agencies to advance the reclassification of cannabis under the Controlled Substances Act.

The portfolio manager noted that while the action does not resolve every regulatory hurdle, it represents a step forward for more than 400,000 American cannabis

AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis

Thu, 18 Dec 2025 16:39:00 -0500

MSOS portfolio manager calls executive action a pivotal moment for cannabis policy

BETHESDA, Md., Dec. 18, 2025 /PRNewswire/ -- AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), today issued the following statement in response to the Executive Order by President Donald J. Trump directing federal agencies to advance the reclassification of cannabis under the Controlled Substances Act.

AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis

Thu, 18 Dec 2025 16:39:00 -0500

MSOS portfolio manager calls executive action a pivotal moment for cannabis policy

AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis

Thu, 18 Dec 2025 16:39:00 -0500

MSOS portfolio manager calls executive action a pivotal moment for cannabis policy

AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis

Thu, 18 Dec 2025 16:39:00 -0500

MSOS portfolio manager calls executive action a pivotal moment for cannabis policy

Trump: order will not legalize marijuana in any way

Thu, 18 Dec 2025 13:47:57 -0500

Trump: order will not legalize marijuana in any way

Thu, 18 Dec 2025 13:47:57 -0500

Trump: order will not legalize marijuana in any way

Thu, 18 Dec 2025 13:47:57 -0500

Trump: order will not legalize marijuana in any way

Trump to sign executive order expediting marijuana reclassification

Thu, 18 Dec 2025 13:45:43 -0500

Trump to sign executive order expediting marijuana reclassification

Investing.com -- President Trump will sign an executive order on Thursday directing the Attorney General to expedite the reclassification of marijuana as a Schedule III substance, according to a Reuters report Thursday.

The order aims to allow more research into medical marijuana and cannabidiol (CBD) while helping the U.S. better understand risks associated with marijuana use. The official noted there is currently insufficient evidence of marijuana's medical uses.

The executive order will direct the White House to collaborate with Congress to improve access to hemp-derived CBD products and develop a new definition for these products.

Trump to sign executive order expediting marijuana reclassification

Thu, 18 Dec 2025 13:45:43 -0500

Trump to sign executive order expediting marijuana reclassification

The executive order will direct the White House to collaborate with Congress to improve access to hemp-derived CBD products and develop a new definition for these products.

Trump to sign executive order expediting marijuana reclassification

Thu, 18 Dec 2025 13:45:43 -0500

Trump to sign executive order expediting marijuana reclassification

The executive order will direct the White House to collaborate with Congress to improve access to hemp-derived CBD products and develop a new definition for these products.

AdvisorShares Highlights the Pending Historic Reforms in US Cannabis Market